Akanda (AKAN) Inventory Average (2022 - 2023)
Akanda (AKAN) posted quarterly Inventory Average of $1.3 million for Q4 2023, up 31.44% year-over-year from $976507.0 in Q4 2022, and up 9.83% quarter-over-quarter from $1.2 million in Q2 2023.
Akanda (AKAN) Inventory Average (2022 - 2023) Analysis & Trends
Akanda's Inventory Average history runs 2 years deep, the most recent figure standing at $1.3 million for Q4 2023.
- In Q4 2023, Inventory Average rose 31.44% year-over-year to $1.3 million; the TTM figure through Dec 2023 stood at $1.3 million (up 31.44% YoY), while the FY2023 annual figure was $1.2 million, changed N/A from the prior year.
- Inventory Average for Q4 2023 stood at $1.3 million, up from $1.2 million in the prior quarter.
- The five-year high for Inventory Average was $1.3 million in Q4 2023, with the low at $976507.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 824.00 Mn |
| 10 | Akanda | 267,491.09 | 267,491.09 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Dec 31, 2022 | 976,507.00 |